BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 33002568)

  • 1. Prediction, identification and progression of histopathological liver disease activity in children with intestinal failure.
    Mutanen A; Lohi J; Merras-Salmio L; Koivusalo A; Pakarinen MP
    J Hepatol; 2021 Mar; 74(3):593-602. PubMed ID: 33002568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variation of plasma citrulline as a predictive factor for weaning off long-term parenteral nutrition in children with neonatal short bowel syndrome.
    Proli F; Faragalli A; Talbotec C; Bucci A; Zemrani B; Chardot C; Abi Nader E; Goulet O; Lambe C
    Clin Nutr; 2021 Aug; 40(8):4941-4947. PubMed ID: 34358840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive value of serum fibroblast growth factor 19 and liver stiffness for intestinal failure associated liver disease-cholestasis.
    Xiao Y; Maitiabula G; Wang H; Xu K; Zhang Y; Fu N; Zhang L; Gao T; Sun G; Song D; Gao X; Wang X
    Clin Nutr ESPEN; 2024 Feb; 59():89-95. PubMed ID: 38220411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pediatric Intestinal Failure-Associated Liver Disease: Challenges in Identifying Clinically Relevant Biomarkers.
    Gura KM; Mulberg AE; Mitchell PD; Yap J; Kim CY; Chen M; Potemkin A; Puder M
    JPEN J Parenter Enteral Nutr; 2018 Feb; 42(2):455-462. PubMed ID: 29443401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum Scoring and Quantitative Magnetic Resonance Imaging in Intestinal Failure-Associated Liver Disease: A Feasibility Study.
    Fragkos KC; Picasso Bouroncle MC; Kumar S; Caselton L; Menys A; Bainbridge A; Taylor SA; Torrealdea F; Kumagai T; Di Caro S; Rahman F; Macnaughtan J; Chouhan MD; Mehta S
    Nutrients; 2020 Jul; 12(7):. PubMed ID: 32707726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum plant sterols, cholestanol, and cholesterol precursors associate with histological liver injury in pediatric onset intestinal failure.
    Mutanen A; Nissinen MJ; Lohi J; Heikkilä P; Gylling H; Pakarinen MP
    Am J Clin Nutr; 2014 Oct; 100(4):1085-94. PubMed ID: 25099547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histopathological liver steatosis linked with high parenteral glucose and amino acid supply in infants with short bowel syndrome.
    Gunnar R; Mutanen A; Merras-Salmio L; Pakarinen MP
    JPEN J Parenter Enteral Nutr; 2023 Jan; 47(1):41-50. PubMed ID: 35633305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence, prevention, and treatment of parenteral nutrition-associated cholestasis and intestinal failure-associated liver disease in infants and children: a systematic review.
    Lauriti G; Zani A; Aufieri R; Cananzi M; Chiesa PL; Eaton S; Pierro A
    JPEN J Parenter Enteral Nutr; 2014 Jan; 38(1):70-85. PubMed ID: 23894170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Approximately 50% of acute intestinal failure (AIF) patients on short-term parenteral nutrition (PN) have intestinal failure-associated liver disease (IFALD) without effect on hospital length of stay and mortality.
    Cheang LY; Chong NCJ; Poh BY; Tan LB; Goh JLR; Lee MS; Tan KCT; Kadir HA; Cheah CCM; Salazar E
    Clin Nutr ESPEN; 2024 Jun; 61():140-144. PubMed ID: 38777425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parenteral plant sterols and intestinal failure-associated liver disease in neonates.
    Kurvinen A; Nissinen MJ; Andersson S; Korhonen P; Ruuska T; Taimisto M; Kalliomäki M; Lehtonen L; Sankilampi U; Arikoski P; Saarela T; Miettinen TA; Gylling H; Pakarinen MP
    J Pediatr Gastroenterol Nutr; 2012 Jun; 54(6):803-11. PubMed ID: 22197940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of Intestinal Failure Associated Liver Disease according to different diagnostic criteria.
    Sasdelli AS; Agostini F; Pazzeschi C; Guidetti M; Lal S; Pironi L
    Clin Nutr; 2019 Jun; 38(3):1198-1205. PubMed ID: 29778510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-Term Outcomes in Children With Intestinal Failure-Associated Liver Disease Treated With 6 Months of Intravenous Fish Oil Followed by Resumption of Intravenous Soybean Oil.
    Wang C; Venick RS; Shew SB; Dunn JCY; Reyen L; Gou R; Calkins KL
    JPEN J Parenter Enteral Nutr; 2019 Aug; 43(6):708-716. PubMed ID: 30411372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficient achievement of enteral autonomy facilitates resolution of liver injury in necrotizing enterocolitis induced short bowel syndrome.
    Mutanen A; Pöntinen V; Gunnar R; Merras-Salmio L; Pakarinen MP
    Sci Rep; 2022 Oct; 12(1):17516. PubMed ID: 36266329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transient elastography and aspartate aminotransferase to platelet ratio predict liver injury in paediatric intestinal failure.
    Hukkinen M; Kivisaari R; Lohi J; Heikkilä P; Mutanen A; Merras-Salmio L; Pakarinen MP
    Liver Int; 2016 Mar; 36(3):361-9. PubMed ID: 26058319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum FGF21 increases with hepatic fat accumulation in pediatric onset intestinal failure.
    Mutanen A; Heikkilä P; Lohi J; Raivio T; Jalanko H; Pakarinen MP
    J Hepatol; 2014 Jan; 60(1):183-90. PubMed ID: 24021426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-Term Fish Oil Lipid Emulsion Use in Children With Intestinal Failure-Associated Liver Disease [Formula: see text].
    Nandivada P; Fell GL; Mitchell PD; Potemkin AK; O'Loughlin AA; Gura KM; Puder M
    JPEN J Parenter Enteral Nutr; 2017 Aug; 41(6):930-937. PubMed ID: 26962059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intestinal failure-associated liver disease in hospitalised children.
    Pichler J; Horn V; Macdonald S; Hill S
    Arch Dis Child; 2012 Mar; 97(3):211-4. PubMed ID: 22247247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversal of intestinal failure-associated liver disease in infants and children on parenteral nutrition: experience with 93 patients at a referral center for intestinal rehabilitation.
    Cowles RA; Ventura KA; Martinez M; Lobritto SJ; Harren PA; Brodlie S; Carroll J; Jan DM
    J Pediatr Surg; 2010 Jan; 45(1):84-7; discussion 87-8. PubMed ID: 20105585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical approach to the management of Intestinal Failure Associated Liver Disease (IFALD) in adults: A position paper from the Home Artificial Nutrition and Chronic Intestinal Failure Special Interest Group of ESPEN.
    Lal S; Pironi L; Wanten G; Arends J; Bozzetti F; Cuerda C; Joly F; Kelly D; Staun M; Szczepanek K; Van Gossum A; Schneider SM;
    Clin Nutr; 2018 Dec; 37(6 Pt A):1794-1797. PubMed ID: 30017241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intestinal Failure-Associated Liver Disease and Growth Pre- and Post-Transition to a Composite Lipid Emulsion.
    Hudson AS; Tyminski N; Turner JM; Silverman JA
    J Pediatr Gastroenterol Nutr; 2023 Jun; 76(6):830-836. PubMed ID: 36930972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.